• Eur J Anaesthesiol · Aug 2015

    Comparative Study Clinical Trial Observational Study

    Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: A prospective observational study.

    • Martin Soehle, Christina F Wolf, Melanie J Priston, Georg Neuloh, Christian G Bien, Andreas Hoeft, and Richard K Ellerkmann.
    • From the University of Bonn, Bonn (MS, AH, RKE), Department of Anaesthesiology and Intensive Care Medicine, Sana Clinic Berlin-Lichtenberg, Berlin, Germany (CFW), C3P Analysis, Pharmacy Department, Plymouth Hospitals NHS Trust, Plymouth, United Kingdom (MJP), Department of Neurosurgery, University of Aachen, Aachen (GN), Department of Epileptology, University of Bonn, Bonn (CGB), Epilepsy Centre Bethel, Mara Hospital, Bielefeld, Germany (CGB) *Drs. Martin Soehle and Christina F. Wolf contributed equally to the writing of this article.
    • Eur J Anaesthesiol. 2015 Aug 1; 32 (8): 527-34.

    BackgroundAnaesthesia for awake craniotomy aims for an unconscious patient at the beginning and end of surgery but a rapidly awakening and responsive patient during the awake period. Therefore, an accurate pharmacokinetic/pharmacodynamic (PK/PD) model for propofol is required to tailor depth of anaesthesia.ObjectiveTo compare the predictive performances of the Marsh and the Schnider PK/PD models during awake craniotomy.DesignA prospective observational study.SettingSingle university hospital from February 2009 to May 2010.PatientsTwelve patients undergoing elective awake craniotomy for resection of brain tumour or epileptogenic areas.InterventionArterial blood samples were drawn at intervals and the propofol plasma concentration was determined.Main Outcome MeasuresThe prediction error, bias [median prediction error (MDPE)] and inaccuracy [median absolute prediction error (MDAPE)] of the Marsh and the Schnider models were calculated. The secondary endpoint was the prediction probability PK, by which changes in the propofol effect-site concentration (as derived from simultaneous PK/PD modelling) predicted changes in anaesthetic depth (measured by the bispectral index).ResultsThe Marsh model was associated with a significantly (P = 0.05) higher inaccuracy (MDAPE 28.9 ± 12.0%) than the Schnider model (MDAPE 21.5 ± 7.7%) and tended to reach a higher bias (MDPE Marsh -11.7 ± 14.3%, MDPE Schnider -5.4 ± 20.7%, P = 0.09). MDAPE was outside of accepted limits in six (Marsh model) and two (Schnider model) of 12 patients. The prediction probability was comparable between the Marsh (PK 0.798 ± 0.056) and the Schnider model (PK 0.787 ± 0.055), but after adjusting the models to each individual patient, the Schnider model achieved significantly higher prediction probabilities (PK 0.807 ± 0.056, P = 0.05).ConclusionWhen using the 'asleep-awake-asleep' anaesthetic technique during awake craniotomy, we advocate using the PK/PD model proposed by Schnider. Due to considerable interindividual variation, additional monitoring of anaesthetic depth is recommended.Trial RegistrationClinicalTrials.gov identifier: NCT 01128465.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.